Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/186526
Title: The presence of non-criteria manifestations negatively affects the prognosis of seronegative antiphospholipid syndrome patients: a multicenter study.
Author: Pires da Rosa, Gilberto
Sousa Pinto, Bernardo
Ferreira, Ester
Araújo, Olga
Barilaro, Giuseppe
Bettencourt, Paulo
Cervera i Segura, Ricard, 1960-
Espinosa, Gerard
Keywords: Malalties autoimmunitàries
Síndrome antifosfolipídica
Autoanticossos
Lupus eritematós
Embaràs
Autoimmune diseases
Antiphospholipid syndrome
Autoantibodies
Lupus erythematosus
Pregnancy
Issue Date: 3-Jan-2022
Publisher: BioMed Central
Abstract: Background: Seronegative antiphospholipid syndrome (SN-APS) is often defned as the presence of APS criteria manifestations, negative antiphospholipid antibodies (aPL), and coexistence of APS non-criteria manifestations. Nevertheless, the impact of these non-criteria features is still unclear. On a diferent note, the relevance of one single aPL positive determination in patients with APS manifestations is another domain with limited evidence. We aim to compare the course of SN-APS and single-positive aPL (SP-aPL) patients with that of individuals with APS manifesta‑ tions without non-criteria features/aPL positivity (controls). Methods: Retrospective analysis of patients with thrombosis/obstetric morbidity assessed in two European hospi‑ tals between 2005 and 2020. Patients were divided into SN-APS, SP-aPL, and control groups. Clinical characteristics, comorbidities, and therapies were compared. Results: A total of 82 patients were included in the SN-APS group, 88 in the SP-aPL group, and 185 in the control group. In Cox regression model, SN-APS displayed more thrombosis recurrence than controls (HR 3.8, 95% CI 2.2-6.5, p<0.001) even when adjusting for the presence of hereditary thrombophilia, systemic lupus erythematosus, or con‑ traceptive hormonal treatment. In SP-aPL, the diference in thrombosis recurrence did not reach statistical signifcance (p=0.078). Indefnite anticoagulation (p<0.001 and p=0.008, respectively) and vitamin K antagonist (VKA) use (p<0.001 in both cases) were more common in SN-APS/SP-aPL. Conclusion: SN-APS displayed more thrombosis recurrence, indefnite anticoagulation, and VKA use than controls without non-criteria manifestations. The presence of such features in patients with thrombosis and negative aPL may negatively impact their clinical course. Keywords: Antiphospholipid syndrome, Antiphospholipid antibodies, Seronegative, Single positive, Non-criteria manifestations
Note: Reproducció del document publicat a: https://doi.org/10.1186/s13075-021-02702-9
It is part of: Arthritis Research & Therapy, 2022, vol. 24, num. 1, p. 9
URI: http://hdl.handle.net/2445/186526
Related resource: https://doi.org/10.1186/s13075-021-02702-9
ISSN: 1478-6362
Appears in Collections:Articles publicats en revistes (Medicina)
Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)

Files in This Item:
File Description SizeFormat 
719910.pdf1.21 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons